Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Yu-Ting Lin, Tamara Will, Charlotte Wickham, Petra Boeree, Dominic Jack & Matthew Keiser. (2023) Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis. Patient Preference and Adherence 17, pages 1923-1933.
Read now
Read now
Francesco Piras, Lilian Arnaud, Eric Henninger, Matthew Keiser, Andrea Seitzinger, Dominic Jack & Quentin Le Masne. (2023) Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years. Expert Opinion on Drug Delivery 20:6, pages 863-870.
Read now
Read now
Beate Bittner, Chantal Schmit Chiesi, Saifuddin Kharawala, Gavneet Kaur & Johannes Schmidt. (2019) Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting. Medical Devices: Evidence and Research 12, pages 101-127.
Read now
Read now
Sibyl Wray, Brooke Hayward, Fernando Dangond & Barry Singer. (2018) Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study. Expert Opinion on Drug Delivery 15:2, pages 127-135.
Read now
Read now
Andrea Zimmer, Michael Coslovsky, Ivo Abraham & Bernhard F Décard. (2017) Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study. Patient Preference and Adherence 11, pages 1815-1830.
Read now
Read now
Marieke Krol, Gert de Voer & Ulrike Osowski. (2017) Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis. Patient Preference and Adherence 11, pages 1189-1196.
Read now
Read now
María Dolores Edo Solsona, Emilio Monte Boquet, Bonaventura Casanova Estruch & José Luis Poveda Andrés. (2017) Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with multiple sclerosis. Patient Preference and Adherence 11, pages 415-421.
Read now
Read now
Alessandra Lugaresi, Francesca De Robertis, Marinella Clerico, Vincenzo Brescia Morra, Diego Centonze, Stefano Borghesan & Giorgia Teresa Maniscalco. (2016) Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study. Expert Opinion on Drug Delivery 13:7, pages 931-935.
Read now
Read now
Damiano Paolicelli, Eleonora Cocco, Valentina Di Lecce, Vita Direnzo, Lucia Moiola, Roberta Lanzillo, Paola Perini, Simona Malucchi, Giovanna Borriello, Emilio Portaccio, Valentina Panetta, Giuseppe Fenu, Francesca Sangalli, Laura Cacciaguerra & Maria Trojano. (2016) Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study. Expert Opinion on Drug Delivery 13:6, pages 799-805.
Read now
Read now
Jakob Lange, Philipp Richard & Nick Bradley. (2015) Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population. Medical Devices: Evidence and Research 8, pages 255-264.
Read now
Read now
Marcello Moccia, Raffaele Palladino, Cinzia Russo, Marco Massarelli, Antonio Nardone, Maria Triassi, Alessandra Lugaresi & Vincenzo Brescia Morra. (2015) How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis. Expert Opinion on Drug Delivery 12:12, pages 1829-1835.
Read now
Read now
Articles from other publishers (8)
Peter Rieckmann, Tjalf Ziemssen, Iris-Katarina Penner, Alaleh Raji, Torsten Wagner, Joachim Richter & Uwe K. Zettl. (2022) Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart® Injector: Results of the Prospective Cohort Study REBIFLECT. Advances in Therapy 39:6, pages 2749-2760.
Crossref
Crossref
Irene Lizano-Díez, Sonia Amaral-Rohter, Lucía Pérez-Carbonell & Susana Aceituno. (2021) Impact of Home Care Services on Patient and Economic Outcomes: A Targeted Review. Home Health Care Management & Practice 34:2, pages 148-162.
Crossref
Crossref
Therese Burke & Joanna Patching. (2021) Conductors of care: exploring the role of the multiple sclerosis nurse in Australasia, phase 2. British Journal of Neuroscience Nursing 17:Sup3, pages S42-S49.
Crossref
Crossref
Sergio Sauri-Suárez, Sandra Quiñones-Aguilar, Arturo Contreras-Marín, Erik Omar Ramiro-Guerrero, David Zúñiga-García, Leticia Salinas-Vázquez, Leonardo Llamas-López, Carolina León-Jiménez, Adriana García-Martell, Iliana González-Hernández, Erwin Chiquete & Silvia García. (2020) Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis. PLOS ONE 15:4, pages e0230959.
Crossref
Crossref
Tanja S. Jørgensen, Marie Skougaard, Peter C. Taylor, Hans C. Asmussen, Anne Lee, Louise Klokker, Louise Svejstrup, Irina Mountian, Henrik Gudbergsen & Lars Erik Kristensen. (2018) The Parker Model: Applying a Qualitative Three-Step Approach to Optimally Utilize Input from Stakeholders When Introducing New Device Technologies in the Management of Chronic Rheumatic Diseases. The Patient - Patient-Centered Outcomes Research 11:5, pages 515-526.
Crossref
Crossref
Ingo Kleiter, Michael Lang, Judith Jeske, Christiane Norenberg, Barbara Stollfuß & Markus Schürks. (2017) Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study. BMC Neurology 17:1.
Crossref
Crossref
Gavin Giovannoni, Helmut Butzkueven, Suhayl Dhib-Jalbut, Jeremy Hobart, Gisela Kobelt, George Pepper, Maria Pia Sormani, Christoph Thalheim, Anthony Traboulsee & Timothy Vollmer. (2016) Brain health: time matters in multiple sclerosis. Multiple Sclerosis and Related Disorders 9, pages S5-S48.
Crossref
Crossref
O. Fernández, R. Arroyo, S. Martínez-Yélamos, M. Marco, J. A. García Merino, D. Muñoz, E. Merino & A. Roque. (2016) Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis. PLOS ONE 11:8, pages e0160313.
Crossref
Crossref